AFAR's Mission

To support and advance Healthy Aging through Biomedical Research

Watch our Live Longer, Live Well video (right) to explore how a better world for older people is a better world for everyone.

Super Agers Social Art Jan2024



Celebrating and Studying
Exceptional Longevity

Learn more

AFAR's Grant Programs

42

Years

4400

Talented Investigators

$

200

Million Funded

Green Spotlight Microscope

Investing in Talent

Novel Interventions

Believing in Innovation

AFAR News

AFAR News
In Memoriam: Norman Volk, Former AFAR Board Member
News Item Logo Template Aging Cell
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
News Item Logo Template Alz Dementia Journal
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
News Item Logo Template Aging Cell
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR News
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors
News Item Logo Template JAGS
AFAR leadership on impact of four AFAR-led NIA programs in special issue of JAGS
I Stock 1452235986
Free Live Better Longer Webinar | March 27, 3pm ET

How Old is Old?

A discussion on Biological Age
hosted by AFAR and Prevention

Learn more and register

AFAR's Leadership

AFAR provides infrastructure support and leadership for three initiatives funded by the National Institute on Aging (NIA).

NSC Whitebox

Providing leadership in the pursuit of basic research into the biology of aging

RCCN White Box

Catalyzing cross-disciplinary research across the NIA center programs

Clin STAR White Box

A national platform to advance transdisciplinary aging research

The TAME Trial

The AFAR-managed TAME (Targeting Aging with Metformin) Trial will establish a proof-of-concept that aging processes can be treated, just as we treat diseases.

The TAME Trial ultimately seeks the FDA to make aging an "indication" for treatment.

If aging is made an indication, the TAME Trial will mark a paradigm shift: from treating each age-related medical condition separately, to treating these conditions together, by targeting aging per se.

Learn about the TAME Trial
Public statements by individual AFAR employees, affiliates, or Board members do not imply endorsement by AFAR. AFAR’s viewpoints are expressed only through official releases after approval by its Executive Director or Board of Directors.

Stay Connected

For updates on AFAR experts, events, articles, and more, subscribe to our newsletter, EncourAGE.

Sign up for Updates here

A Healthier Tomorrow
Starts Today

AFAR-supported investigators are advancing research that will help us all live healthier, longer. Your support is vital to help strengthen the vital research pipeline.

Giving Opportunities

AFAR is grateful for the collaboration and support of our program partners, including:

Gilbert Foundation logo 2024 Green
Glenn White Box


David Gore

Hevolution whitebox
Mc Knight Whitebox
Sagol Whitebox

AFAR is proud to consistently receive the highest ratings from respected charity evaluators

CharityNavigator4StarBadge.png
Guidestar Sealof Transparency